Latest News

Federal regulators rejected the initial Union Pacific and Norfolk Southern merger application. The Surface Transportation Board requested a revised filing with additional information. Analysts reacted with downgrades, citing higher uncertainty around the proposed deal. For investors watching NYSE:UNP, this decision places one of the largest US freight rail operators in a holding pattern on a major deal. Union Pacific is a core player in long haul freight, and any change in its network or...

Why Goldman Sachs Group (GS) Is Back in Focus After Its Latest Quarter Goldman Sachs Group (GS) just paired record Q4 and full year results with a higher dividend, larger buybacks, and a clear move away from consumer finance by exiting its Apple Card partnership. Management also pointed to a multi year high investment banking backlog and a supportive regulatory backdrop, which it expects to help investment banking activity pick up through 2026. This puts the spotlight back on GS as a capital...

Recent performance snapshot and what it might mean Baldwin Insurance Group (BWIN) has quietly put together a mixed return profile, with a gain over the past month and past 3 months, but a 1 year total return decline and a modest 5 year result. At a last close of US$26.26, the insurer carries a value score of 1, supported by reported revenue of US$1.49b and a net loss of US$28.11 million. This combination raises both scale and profitability questions for investors. See our latest analysis for...

Why IAMGOLD’s latest production update matters for shareholders IAMGOLD (TSX:IMG) attracted fresh attention after reporting record fourth quarter and full year 2025 gold production, alongside 2026 guidance calling for 720,000 to 820,000 ounces of attributable output. For you as an investor, this combination of record reported volumes, forward production expectations, and ongoing expansion plans is the core backdrop for reassessing how IAMGOLD’s current share price lines up with its recent...

Waystar Holding recently announced the introduction of agentic intelligence to its cloud-native platform, enhancing its AltitudeAI™ capabilities to automate revenue cycle workflows and reduce administrative burdens across clinical, financial, and administrative processes. A distinctive aspect of this update is Waystar’s use of a unified data network that processes more than 7.50 billion annual transactions and one in three U.S. hospital discharges to fuel self-learning, agent-powered...

LTC Properties recently reported third-quarter 2025 results showing revenue ahead of expectations but earnings per share below forecasts, and it amended its credit agreement to add US$200 million to its credit facility, events that occurred prior to today. This combination of stronger-than-expected revenue and increased financial flexibility offers a clearer view of how LTC Properties is positioning its balance sheet. Against this backdrop, we’ll explore how the expanded US$200 million...

AvalonBay Communities, NYSE:AVB, has released the final tax treatment classification for its 2025 dividend distributions. The update details how different portions of the 2025 dividends will be categorized for tax purposes under current regulations. The announcement gives existing and prospective shareholders clearer information for tax planning around AVB’s upcoming payouts. AvalonBay Communities, NYSE:AVB, is putting hard numbers around its 2025 dividend tax classifications at a time...

Key Insights The projected fair value for Vantage Towers is €43.26 based on Dividend Discount Model With €38.20 share...

As the Middle East market shows resilience with most Gulf markets gaining ahead of earnings and Dubai reaching its strongest level in nearly two decades, investors are keenly observing how upcoming fourth-quarter reports might influence sentiment. Amidst this backdrop, identifying promising stocks involves looking for companies with strong fundamentals and growth potential that can thrive even as oil price volatility and cautious investor sentiment persist.

Key Insights Using the 2 Stage Free Cash Flow to Equity, Sunrise Communications fair value estimate is CHF55.70 Sunrise...

Why recent attention on Catalyst Pharmaceuticals matters Recent commentary around Catalyst Pharmaceuticals (CPRX) has focused on its rare disease portfolio, with FIRDAPSE and AGAMREE at the center, alongside upcoming trial readouts, regulatory events, and earnings performance. Investors are also watching the company’s efforts to promote a higher approved FIRDAPSE daily dose and reach additional patient groups, in the context of fresh media coverage and growing interest in the stock. See our...

ARB Corporation Limited recently reported unaudited half-year sales revenue to 31 December 2025 of A$358.0 million, representing a 1.0% decline from the prior corresponding period. The marginal revenue decrease highlights how even small shifts in demand can draw closer attention to ARB’s underlying business trends and resilience. With this slight revenue decline as a backdrop, we’ll examine what the latest update means for ARB’s broader investment narrative. Uncover the next big thing with...

What Boeing’s recent performance might mean for investors Boeing (BA) has drawn fresh attention after a period of solid share price moves, with the stock up 16.3% over the past month and 14.9% over the past 3 months, based on the data provided. See our latest analysis for Boeing. Set against a longer track record, Boeing’s recent share price momentum looks more than just a short-term bounce. A 30 day share price return of 16.3% and a 1 year total shareholder return of 41.8% point to stronger...

BYD is keeping a strong focus on cost leadership and accessible pricing, which is structurally limiting its profit margins. This holds true even as the company pushes into higher-end segments with premium models such as the Yangwang series. The setup suggests BYD may rely more on scale and broader revenue streams than on luxury level margins from premium vehicles. For investors watching BYD (SEHK:1211), the key tension is clear: the company is positioning itself as a volume leader while...

Hims & Hers Health (NYSE:HIMS) is in discussions with Novo Nordisk to add Wegovy injections to its telehealth platform. The talks also include potential access to an oral version of Wegovy for weight management. The move would introduce a new category of prescription weight loss treatments to the company’s existing offerings. Hims & Hers Health runs a direct-to-consumer telehealth and subscriptions model focused on areas like hair loss, mental health, skincare, and sexual health. Bringing a...

Yum China Holdings (NYSE:YUMC) announced that board member Robert B. Aiken will not seek re election at the company’s 2026 Annual Meeting. The decision is linked to Aiken’s future professional commitments, as disclosed by the company. Aiken’s planned departure affects board committee roles tied to food safety and sustainability oversight. Yum China Holdings, the licensee of KFC, Pizza Hut and other brands in China, sits at the intersection of consumer spending, food services and supply...

Why General Electric is back in focus for investors General Electric (GE) is on many investors’ radar again as they weigh its current share price around $312 against recent returns, revenue of $43.95b, and net income of $8.05b. See our latest analysis for General Electric. Recent trading has been choppy, with a 1 day share price return of a 3.93% decline and a 7 day share price return of a 4.55% decline. However, the 1 year total shareholder return of 67.53% and very large 5 year total...

Multiple major firms, including Goldman Sachs, Barclays, and KeyBanc Capital Markets, recently upgraded their views on Applied Materials (NasdaqGS:AMAT). Analysts cited sector tailwinds tied to rising demand for AI focused semiconductor equipment and advanced chip manufacturing. AI logic, DRAM, and HBM are key end markets where capital spending by major chipmakers is currently a focus. Applied Materials (NasdaqGS:AMAT) sits at the center of the semiconductor capital equipment market,...

If you are wondering whether Salesforce is starting to look like value after a rough patch, this article walks through what the current share price might be offering you. The stock closed at US$220.07, with returns of an 8.7% decline over 7 days, a 15.3% decline over 30 days, a 13.2% decline year to date and a 32.2% decline over 1 year, set against a 43.8% gain over 3 years and a 1.6% decline over 5 years. These swings have kept Salesforce in focus as investors reassess what they are willing...

Elekta (OM:EKTA B) has attracted fresh attention after its Elekta Evo CT-Linac received FDA 510(k) clearance, opening the door for U.S. adoption of its AI supported imaging and radiation therapy platform. See our latest analysis for Elekta. The FDA clearance arrives at a time when Elekta’s share price has a 90 day share price return of 20.20% and a 30 day share price return of 6.47%, while the 1 year total shareholder return of a 2.89% decline and 5 year total shareholder return of a 40%...

Trump administration outlines a proposal for a US$200b mortgage bond purchase program involving Fannie Mae and Freddie Mac. Plan includes new limits on institutional home buyers and expanded access to downpayments using 401(k) retirement funds. Measures target the U.S. housing and mortgage markets and could influence Federal National Mortgage Association (OTCPK:FNMA) and sector participants. Federal National Mortgage Association, or Fannie Mae, operates at the core of the U.S. mortgage...

If you are wondering whether Fortune Brands Innovations is offering value at its current share price, this article walks through what the numbers are really saying about the stock. The share price recently closed at US$58.98, with a 15.6% return over the last 30 days but a 19.2% decline over the past year, which can change how investors view both its potential and its risk. Recent news around the company has focused on its positioning within the capital goods sector and how investors are...

If you are wondering whether Graphic Packaging Holding is trading at an attractive price today, the key question is whether the current share price properly reflects the value of its business. The stock last closed at US$14.79, with returns of a 4.9% decline over 7 days, a 4.1% decline over 30 days, a 2.4% decline year to date, a 46.6% decline over 1 year, a 32.0% decline over 3 years, and a 3.4% decline over 5 years. These moves have kept valuation on many investors' radar, especially as...

If you are wondering whether Acadia Healthcare Company stock is priced attractively right now, you are not alone. Recent moves have put valuation firmly in the spotlight. The share price recently closed at US$14.24, with a 13.5% gain over the last 7 days, a 1.2% decline over 30 days, a 0.3% decline year to date, and longer term returns of a 67.9% decline over 1 year, an 83.1% decline over 3 years, and a 72.1% decline over 5 years. Recent coverage of Acadia Healthcare Company has focused on...